| 15578974
|
Recent advances in rhinovirus therapeutics. |
Curr Drug Targets Infect Disord |
2004 |
Charles CH;Yelmene M;Luo GX |
View
More |
| 15906188
|
18th International Conference on Antiviral Research. Respiratory viruses. |
IDrugs |
2005 |
Kibble A |
View
More |
| 20075029
|
Antibiotic prescription pattern for viral respiratory illness in emergency room and ambulatory care settings. |
Clin Pediatr (Phila) |
2010 |
Nadeem Ahmed M;Muyot MM;Begum S;Smith P;Little C;Windemuller FJ |
View
More |
| 21183345
|
Non-covalent inhibitors of rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2011 |
Baxter A;Chambers M;Edfeldt F;Edman K;Freeman A;Johansson C;King S;Morley A;Petersen J;Rawlins P;Spadola L;Thong B;Van de Poel H;Williams N |
View
More |
| 23650168
|
Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. |
Antimicrob Agents Chemother |
2013 |
Spickler C;Lippens J;Laberge MK;Desmeules S;Bellavance E;Garneau M;Guo T;Hucke O;Leyssen P;Neyts J;Vaillancourt FH;Decor A;O'Meara J;Franti M;Gauthier A |
View
More |
| 24366736
|
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C. |
Antimicrob Agents Chemother |
2014 |
Mello C;Aguayo E;Rodriguez M;Lee G;Jordan R;Cihlar T;Birkus G |
View
More |
| 32907596
|
In vitro virucidal activity of Echinaforce(R), an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. |
Virol J |
2020 |
Signer J;Jonsdottir HR;Albrich WC;Strasser M;Zust R;Ryter S;Ackermann-Gaumann R;Lenz N;Siegrist D;Suter A;Schoop R;Engler OB |
View
More |
